SaniSure Announces the Acquisition of GL Engineering to Globally Expand its Drug Product Fill and Finish Solutions

SaniSure | January 11, 2022

SaniSure Announces the Acquisition
SaniSure, a global developer and manufacturer of single-use technology for the biopharmaceutical industry, announced it has acquired GL Engineering (GLE) of East Hanover, New Jersey.  With this acquisition, SaniSure will expand its global integrated offering of drug product fill and finish bioprocessing assemblies and solution including:
  • Adding new capabilities and manufacturing capacities for drug product filling needles and assemblies.
  • GLE will become the center of excellence for the development of drug product filling solutions.
  • Extension of the SaniSure sterile manufacturing platform with a strong focus on final filling.
The acquisition complements each company's technical capabilities, product offering and  commercial reach. SaniSure has a direct sales force in the US and Europe together with strategic regional distributors and manufacturer representatives. GLE is a leader in filling needle design and manufacturing.

"We are very excited about the addition of GLE to our innovative product portfolio, GLE's high-quality, global standards filling needle line represents an important expansion to SaniSure's customer-focused solutions. Drug product filling solutions are a critical step in many of our customers' processes. Having the ability to vertically integrate GLE's solutions is quite unique," 

-SaniSure's CEO Thomas J. Hook.

Global demand for single-use technology is increasing rapidly with increasing R&D activities, a high level of biotech investments and strong global markets fueling a double-digit market growth rate. "SaniSure's assembly capabilities and commercial reach will significantly enhance the commercialization of our unique single-use needle design," said GL Engineering Founder Gerhard Liepold. Liepold, who will now join SaniSure as the Global Product Manager for Drug Product Filling Solutions, said "we are very proud to join the SaniSure team and bring more than two decades of pharmaceutical industry experience with strong engineering and commitment to design innovation in the single-use market."

About SaniSure
SaniSure is a global leader in the design and manufacturing of single-use systems and components for drug and vaccine manufacturing and other biotech and pharmaceutical applications. With the consolidation of several acquisitions under one roof, the combined resources, competencies and ability to create value for customers is unmatched in the industry. SaniSure's core manufacturing capabilities include injection molding, injection stretch blow molding, cleanroom assembly, tubing extrusion, fabrication, filling-needle manufacturing, and many additional proprietary technologies.SaniSure offers a wide range of  single-use technology products including sterile single-use assemblies PharmaTainer™ bottles and carboys, Mixed4Sure™ mixing solutions, Cap2V8® bottle closures, Pharma-Clear® Silicone Tubing, Cellgyn® TPE tubing, aSURE® fittings, Pharma- Line™ I tubing, and many more. SaniSure has a growing global footprint of five manufacturing sites worldwide to provide customers with an unrivaled level of vertical integration and supply-chain security.

About GL Engineering
GL Engineering provides the highest quality, innovative design, prototyping, manufacturing  and installation of sterile process engineering concepts and solutions, including custom-made, single-use filling needles and thermocouple testing clamps for the pharmaceutical industry.With more than two decades of experience in the pharmaceutical industry, our engineers are committed to designing the best possible products and services to optimize your filling process. GL Engineering provides customers with a customized approach to the cleanest and most efficient filling options on any brand of filling equipment.


From lightweight, high-strength structures to hyper-realistic prototypes, 3D printing has found its way into a variety of applications. This process of additive manufacturing (AM) is becoming more common in highvolume production of designs with moderately complex geometries.

Other News

HWAFUNE Breaks Through Textile Difficulties with Porlite by Creating New Trends in Functional Fabrics

HWAFUNE | June 28, 2022

When mentioning Taiwan's traditional manufacturing, what pops into your head may be the textile industry. As a global hub for textile manufacturing, Taiwan has undergone significant changes over the past 30 years. Two of the most important changes are the relocation of industries to China and the government's New Southbound Policy. While Taiwanese textile manufacturers' decision to relocate is mainly driven by the need to reduce costs using cheap overseas labor, the rising labor costs in Southeast Asia have forced the manufacturers to constantly move their production to other regions, turning them into textile industry nomads. Despite these two relocation trends, HWAFUNE Textile which specializes in manufacturing functional fabrics has insisted on keeping production in Taiwan to provide reliable, high-quality products for esteemed customers. Instead of blindly pursing low costs and low prices through contract manufacturing and ending up in the red ocean, HWAFUNE Textile has strengthened the foothold of the Taiwanese textile industry in the global luxury market. One of the hot topics in the functional apparel market in recent years is the European Union's ban on fabrics containing PTFE. Currently, membranes made of PU, TPU, and PTFE account for the majority of functional apparels. With superior moisture permeability and breathability, PTFE has been adopted more widely than the other two materials. However, when heated to high temperatures during the manufacturing process, PTFE will generate PFOA which is classified as a possible human carcinogen. In addition, greenhouse gas is produced when fabrics containing this material are incinerated. Even if the fabrics are buried in landfills, PFOA will not decompose and will be washed into the ocean by rain. It then gets into the atmosphere via evaporation and is transported to everywhere by airflow or rain. PFOA has even been found in polar bears' livers. Considering the potential impact of the EU's ban on the clothing market and consumers' fear of toxic substances, upmarket brands have been looking for alternative functional fabrics. Therefore, HWAFUNE has joined hands with Phoenix Innovative Materials to develop the functional fabric brand Porlite, which has rapidly won the heart of high-end functional apparel brands. "In Light of Future Trends, HWAFUNE Develops Porlite Fabrics with Phoenix Innovative Materialsto take interest in PP membranes five years ago. Although HWAFUNE has the ability to mass produce fabrics featuring PTFE, PU, and TPU membranes, he believes PP membranes will become a trend in the functional apparel industry since the lifecycle of the material, from the production of the membrane and the manufacturing of the fabrics to the disposal of the clothing, is more in line with increased environmental awareness, I can guarantee that Porlite is capable of replacing existing functional fabrics and can fully address high-end brands' product development requirements" -Jackson Chang,ChairmanHWAFUNE. Turning the ambitious vision into reality is not easy. In the past three years, these two companies worked closely on the manufacturing, testing, and modification of the membrane. Besides functionality, HWAFUNE also considered the needs of consumers during testing, such as waterproof, moisture permeability, and even the appearances of the fabrics after washing. The reason that Chairman Chang is so committed is because he has put himself in consumers' shoes in the first place. He thinks environmental protection, safety, non-toxicity, and practicability should be combined perfectly. Product developers should not need to choose between them, nor should they force consumers to compromise on environmental protection, price, or quality. Dr. Chang, who is responsible for technology development at Phoenix Innovative Materials, explains the three major advantages of Porlite which is produced through non-toxic manufacturing processes in Taiwan. Firstly, there are 10 billion pores arranged in an orderly manner on the membrane. As the pores are smaller than water molecules and bigger than air molecules, the fabric can resist water penetration, even under pressure, while maintaining breathability. Moreover, since most outdoor exercises are relatively intense and will create a lot of sweat during the process, Porlite can also transport moisture from the clothing to the atmosphere by diffusion through the membrane, thus providing moisture permeability and breathability that no other functional apparel on market can achieve. Porlite Captures Top Brands' Heart with Non-Toxic Manufacturing, Sustainability, Fastness to Washing, and Moisture Permeability In line with the HWAFUNE's commitment to sustainability, the Durable Water Repellent (DWR) for Porlite can endure at least 30 laundering cycles and rain-resistant for period of time, thus providing a longer life span. Manufacturing in Taiwan is one of the main reasons that Porlite has won favor with Europe-based tier-one sportswear brands. The high quality enables Porlite to stand out from other competitors and meet customers' needs for upscale and reliable products. Both the PP membrane developed by Phoenix Innovative Materials and the Porlite fabric created by HWAFUNE are manufactured in Taiwan. Thanks to their insistence on domestic production, the companies have established a high-tech brand image for Taiwanese textile companies widely recognized by overseas esteemed customers. These are valuable experiences for both Phoenix Innovative Materials and HWAFUNE. Instead of pursuing short-term profits through contract manufacturing services, Chairman Chang and Dr. Chang spent five years developing the Porlite fabric whose overwhelming advantages for environmental protection and functionality have spoken for itself. The goal is to establish bio-based manufacturing processes by using natural materials such as weeds as raw materials and to provide biodegradable products in 10 years.

Read More


Crown Laboratories Announces Expansion of Manufacturing Facility

Crown Laboratories, Inc. | July 13, 2022

Crown Laboratories ("Crown"), a leading, fully integrated global skincare company, announced today that it is adding 60,000 square feet to its manufacturing complex in Johnson City, TN. The facility is home to leading dermatological brands such as PanOxyl® acne wash, Blue Lizard® Australian Sunscreen, and Sarna® anti-itch lotion. The additional 60,000 sq. ft. will bring the Lafe Cox Drive facility to approximately 250,000 square feet – enough to accommodate the warehouse space that is required to keep up with Crown's growing manufacturing and packaging needs. The facility manufactures and distributes products for the global market, including prescription, medical devices, OTC and cosmetic products. It has been producing record numbers of finished goods on a consistent month over month basis. "We have been at maximum capacity for some time now, Our organization has grown significantly and as a result, our production demands have nearly doubled in the past couple of years. With that increased production comes additional componentry, cartons and materials. By expanding our warehouse and adding close to 5,000 pallet locations, we will be able to conduct our operations with more efficiency and with better financial controls." -Jeff Bedard, President and CEO of Crown. About Crown Laboratories, Inc. Crown, a privately held, fully integrated global skincare company, is committed to developing and providing a diverse portfolio of aesthetic, premium and therapeutic skincare products that improve the quality of life for its consumers throughout their skincare journey. An innovative company focused on skin science for life, Crown's unyielding pursuit of delivering therapeutic excellence and enhanced patient outcomes is why it has become the leader in dermatology and aesthetics. Crown has been listed on the Inc. 5000 Fastest Growing Privately Held Companies List for eight years and has expanded its distribution to over 38 countries.

Read More


Saint-Gobain Bioprocess Solutions Business Announces C-Flex® Production Capability in Suwa, Japan

Saint-Gobain Bioprocess Solutions Business Announces C-Flex | June 16, 2022

Saint-Gobain Life Sciences today announced the addition of their Suwa, Japan manufacturing facility for the production of C-Flex® TPE tubing for use in bioprocessing. The capacity addition in Suwa is part of Saint-Gobain Life Sciences ongoing investment plan to globally expand production capacity for its products and services used throughout the bioprocessing industry. The Suwa site expansion further enhances our global manufacturing network, with a specific emphasis on supporting availability of our C-Flex® TPE tubing in Asia, With the completion of Suwa’s capability, we will have C-Flex® production capacity in five separate facilities in four countries. This is a unique capability in TPE tubing for bioprocessing and it supports our mission to provide security of supply.” Benjamin Le Quéré, Bioprocess Solutions business unit General Manager at Saint-Gobain Life Sciences. The C-Flex® production expansion to the Saint-Gobain facility in Suwa, Japan is part of a multi-year manufacturing strategy, increasing Bioprocess Solutions business unit production capacity around the globe, creating redundant manufacturing capabilities across Europe, North America, and Asia to support increasing customer demand. The Saint-Gobain Suwa facility has been in operation since 1992 and employs approximately 100 employees, providing production capability to multiple businesses within the Saint-Gobain Group. About Saint-Gobain Life Sciences Dedicated to improving the quality of life, Saint-Gobain Life Sciences develops and manufactures high-performance components and integrated solutions that touch a broad range of patient care, from the development of new therapeutic cancer treatments to biopharmaceutical production, on through to intravenous therapies for drug delivery. Combining our technical expertise, global manufacturing capabilities and research and development resources, Saint-Gobain Life Sciences is dedicated to meeting the evolving needs of bioprocess, medical, and pharmaceutical customers around the world. Saint-Gobain Life Sciences is part of Saint-Gobain Group, a worldwide leader in light and sustainable construction, which designs, manufactures, and distributes materials and services for the construction and industrial markets.

Read More


Flyability releases the Elios 3, an indoor LiDAR drone for Industry 4.0

Flyability | May 23, 2022

Flyability unveils the Elios 3, the world's first collision-tolerant drone equipped with a LiDAR sensor for indoor 3D mapping. The drone is powered by a new SLAM engine called FlyAware™ that lets it create 3D models as it flies and accompanied by a new version of Flyability's software for inspectors, Inspector 4.0. Flyability pioneered confined space inspection drones with its first product in 2016. With the launch of the Elios 3, it continues its pledge to create cutting edge technology designed to keep humans out of dangerous places to perform the most demanding inspection tasks. The Elios 3 was made to address the need companies have for reliable inspection tools. As industries around the world scale up their use of drones, they need technology that is easy to use, performs the same way every time, and remains stable when working inside highly sensitive assets. "The Elios 3 has some of the very best stabilization in the world, a modular payload, the ability to create 3D models in real time while in flight, and it paves the way towards an increasingly autonomous future, For industrial inspections, the Elios 3 is a key enabler of Industry 4.0, presenting an inspection solution that can make inspections safer, more efficient, and less expensive than ever before." Patrick Thévoz, co-founder and CEO of Flyability The Elios 3 comes with an Ouster OS0-32 LiDAR sensor, allowing inspectors to collect data for the creation of survey-grade 3D models using software from Flyability's new partner, GeoSLAM. Mapping areas that are out of reach or too dangerous for humans is very difficult, yet critical to support operational decisions in many industries. By combining the best of confined space drone data capture and 3D geospatial software technology, Flyability's partnership with GeoSLAM enables professionals to produce survey-grade point clouds of the most inaccessible places in their workplace, completely removing the strain of approximations and guesswork from their operations. In addition to carrying a LiDAR sensor, the Elios 3 can accommodate a second payload that allows it to be customized for each individual user's needs. The Elios 3 is powered by Flyability's new proprietary SLAM engine FlyAware™, allowing it to turn the drone's LiDAR data into 3D models in real time, while the drone is in flight. FlyAware™ also gives the Elios 3 groundbreaking stability, combining data from the drone's three optical cameras and its LiDAR sensor to catch the tiniest unpredictable movement and instruct the flight controller to compensate for it. This stability and other ease-of-use features make the Elios 3 incredibly easy to operate, so that new pilots can be trained and perform their first inspection in the same day. Using Flyability's new Inspector 4.0 software made for reporting with the Elios 3, inspectors can now visualize Points of Interest found during an inspection in a high-resolution 3D map using Inspector 4.0's 3D Map Viewer. This feature lets stakeholders navigate from POI to POI in a digital representation of their assets, providing a clear visualization of the defects found within them to support planning, monitoring, and maintenance efforts. "The Elios 3 is the single biggest project that Flyability has ever undertaken," said Adrien Briod, CTO of Flyability. "If you think of the Elios 2 as your classic flip phone, only designed to make phone calls, the Elios 3 is the smartphone. It's made to be customized for the specific demands of each user, letting you attach the payload you need so you can use the tool as you like, and allowing it to grow and improve over time with new payloads or software solutions." Flyability has been working on the Elios 3 for four years. In that time, its engineers have spent thousands of hours on research and development and performed over 200 missions in the field to collect feedback, learn what clients want, and refine the technology in order to make the most reliable indoor drone on the market. As part of the effort to make the Elios 3, Flyability collaborated with top universities around the world by joining Team Cerberus, which competed in and won DARPA's multi-year Sub-T challenge for autonomous robotics in underground environments. About Flyability Flyability pioneered confined space inspection drones, creating new technology that allows inspectors to collect data remotely inside dangerous confined spaces instead of in person. Since launching in 2014, Flyability has become a trusted provider of internal inspection solutions, enabling remote data collection with cutting edge hardware and software for inspection professionals to help them improve safety, reduce downtimes, and cut costs for their internal inspections. Today Flyability has offices in Switzerland, China, Singapore, and the U.S., with almost one thousand clients in over 60 countries. Flyability works in every industry that requires internal inspections, including Power Generation, Oil & Gas, Mining, Wastewater Infrastructure, Chemicals, Maritime, and Infrastructure & Utilities.

Read More


From lightweight, high-strength structures to hyper-realistic prototypes, 3D printing has found its way into a variety of applications. This process of additive manufacturing (AM) is becoming more common in highvolume production of designs with moderately complex geometries.